| Authors: |
Miyazawa Y; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Wada T; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan. Electronic address: twada@pha.u-toyama.ac.jp., Iwasa Y; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Fuse K; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Shioneri H; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Onogi Y; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan., Sameshima A; Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama, Japan., Yoshida T; Department of Molecular Neuroscience, University of Toyama, 2630 Sugitani, Toyama, Japan., Takasaki I; Department of Pharmacology, Graduate School of Science and Engineering, University of Toyama, 3190 Gofuku, Toyama, Japan., Mori H; Department of Molecular Neuroscience, University of Toyama, 2630 Sugitani, Toyama, Japan., Koizumi K; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan; Division of Presymptomatic Disease, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, Japan., Tsuneki H; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan; Department of Integrative Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Saito S; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan., Sasaoka T; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan. Electronic address: tsasaoka@pha.u-toyama.ac.jp. |
